Hwail Pharmaceutical Co.,Ltd. (061250.KQ)
- Previous Close
1,104.00 - Open
1,113.00 - Bid 1,115.00 x --
- Ask 1,116.00 x --
- Day's Range
1,105.00 - 1,129.00 - 52 Week Range
1,003.00 - 2,185.00 - Volume
618,802 - Avg. Volume
161,597 - Market Cap (intraday)
89.877B - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 27, 2019
- 1y Target Est
--
Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.
www.hwail.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 061250.KQ
View MorePerformance Overview: 061250.KQ
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 061250.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 061250.KQ
View MoreValuation Measures
Market Cap
88.91B
Enterprise Value
20.01B
Trailing P/E
12.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
0.44
Enterprise Value/Revenue
0.17
Enterprise Value/EBITDA
2.06
Financial Highlights
Profitability and Income Statement
Profit Margin
1.78%
Return on Assets (ttm)
1.05%
Return on Equity (ttm)
1.94%
Revenue (ttm)
107.87B
Net Income Avi to Common (ttm)
1.92B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
11.83B
Total Debt/Equity (mrq)
16.15%
Levered Free Cash Flow (ttm)
9.91B